ENSG: Raised 2026 guidance after record results, strong acquisitions, and industry-leading quality metrics
Record quarterly results with strong revenue and earnings growth, driven by high-quality clinical outcomes, robust acquisition activity, and improved operational metrics. Raised 2026 guidance reflects confidence in continued expansion and stable reimbursement, supported by strong liquidity and disc…